Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Cell Carcinoma Treatment With Activated Tumor- Infiltrated Lymphocytes. A Non-Randomized Phase II Trial.

NCT00151645 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT00151645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00151645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Cell Carcinoma Treatment With Activated Tumor- Infiltrated Lymphocytes. A Non-Randomized Phase II Trial.
Lead sponsor
Rennes University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2003
Completion date
July 31, 2005
Enrollment
36
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell carcinoma